港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

巨子生物

78.950

+1.8502.40%

成交量：645.65萬

成交額：5.09億

市值：817.92億

市盈率：35.30

高：80.150

開：77.000

低：76.200

收：77.100

資料載入中...

總覽公司新聞公告

鉅子生物(02367)4月28日發行3500萬股

鉅子生物完成配售合共3500萬股

格隆汇资讯

每日賣空追蹤 | 鉅子生物 04月28日賣空量成交70.48萬股，賣空比例為10.92%

鉅子生物：盤中漲近 3% 儲備 9 種膠原

鉅子生物盤中漲近3% 機構指中國重組膠原蛋白全球化提速

港股異動 | 鉅子生物(02367)漲近3% 機構指中國重組膠原蛋白全球化提速建議關注行業龍頭佈局

智通财经网

中信證券：中國重組膠原蛋白全球化提速 “原料、妝、械”全面出海

財報對對碰丨風口上的重組膠原蛋白生意：錦波生物毛利率連漲4年，鉅子生物連年下滑

鉅子生物(02367)股東將股票由高盛(亞洲)證券轉入花旗銀行轉倉市值26.07億港元

智通财经网

年入55億、毛利超八成，“饅化臉”風波刺破鉅子生物神話

“風暴眼”中的鉅子生物：市場優勢漸失，至今未拿到Ⅲ類醫療器械批文

鉅子生物盤中漲超5% 陝西省藥監局通報多批次可復美產品均未檢出EGF

港股異動 | 鉅子生物(02367)早盤漲超5% 陝西省藥監局通報多批次可復美產品均未檢出EGF

智通财经网

鉅子生物盤中異動早盤股價大漲5.06%報75.750港元

不差錢的鉅子生物連續高位融資，主力產品遭投訴

鉅子生物旗下可復美檢出違禁成分？陝西省藥監局通報

南方都市报

主品牌深陷EGF添加門鉅子生物業績或將面臨劇烈波動- DoNews

每日賣空追蹤 | 鉅子生物 04月17日賣空量成交184.6萬股，賣空比例為3.05%

北水動向|北水成交淨買入23.09億北水繼續加倉科網股全天拋售小米(01810)超13億

北水動向 | 北水淨入23億港元，買鉅子生物、泡泡瑪特、赤峯黃金，沽盈富基金

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02367/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02367","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02367\",,,,,undefined,":{"symbol":"02367","market":"HK","secType":"STK","nameCN":"巨子生物","latestPrice":78.95,"timestamp":1745827737031,"preClose":77.1,"halted":0,"volume":6456531,"delay":0,"floatShares":1036000000,"shares":1036000000,"eps":2.236496005933728,"marketStatus":"未開盤","change":1.85,"latestTime":"04-28 16:08:57","open":77,"high":80.15,"low":76.2,"amount":509424725,"amplitude":0.051232,"askPrice":78.95,"askSize":1800,"bidPrice":78.7,"bidSize":800,"shortable":3,"etf":0,"ttmEps":2.193530473139213,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1745890200000},"marketStatusCode":0,"adr":0,"listingDate":1667491200000,"exchange":"SEHK","adjPreClose":77.1,"dividendRate":0.012286,"openAndCloseTimeList":[[1745803800000,1745812800000],[1745816400000,1745827200000]],"volumeRatio":0.352775,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02367\",,,,,undefined,":{"symbol":"02367","floatShares":1036000000,"roa":"21.88%","roe":"35.88%","lyrEps":2.23648,"volumeRatio":0.352775,"shares":1036000000,"dividePrice":0.97,"high":80.15,"amplitude":0.051232,"preClose":77.1,"low":76.2,"week52Low":35,"pbRate":"10.81","psRate":"13.87","week52High":80.8,"institutionHeld":0,"latestPrice":78.95,"committee":-0.384615,"eps":2.236479714560516,"divideRate":0.012286,"volume":6456531,"delay":0,"ttmEps":2.1935144947410876,"open":77,"prevYearClose":49.9,"prevWeekClose":77.1,"prevMonthClose":70.45,"prevQuarterClose":70.45,"fiveDayClose":72.1,"twentyDayClose":68,"sixtyDayClose":54},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02367\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530288351","title":"鉅子生物(02367)4月28日發行3500萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2530288351","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530288351?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 21:05","pubTimestamp":1745845500,"startTime":"0","endTime":"0","summary":"智通财经APP讯，巨子生物(02367)发布公告，按照日期为2025年4月16日的配售及认购协议，于2025年4月28日根据一般授权发行3500万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286723.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","BK1207","02367","SG9999004311.SGD"],"gpt_icon":0},{"id":"2530886092","title":"鉅子生物完成配售合共3500萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2530886092","media":"格隆汇资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530886092?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 21:03","pubTimestamp":1745845430,"startTime":"0","endTime":"0","summary":"格隆汇4月28日丨巨子生物(02367.HK)公告，公司欣然宣布，卖方配售已于2025年4月23日完成，而认购则已于2025年4月28日完成。补足卖方所持有的合共3500万股股份已按每股66.65港元的配售价成功配售予不少于六名专业、机构及╱或个人投资者，据董事作出一切合理查询后所深知、尽悉及确信，该等投资者连同彼等各自最终实益拥有人均为独立于本公司或其关连人士且与彼等概无关连的第三方。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821040894e5e99e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821040894e5e99e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","LU2488822045.USD","02367","SG9999004311.SGD"],"gpt_icon":0},{"id":"2530516285","title":"每日賣空追蹤 | 鉅子生物 04月28日賣空量成交70.48萬股，賣空比例為10.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530516285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530516285?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 20:37","pubTimestamp":1745843826,"startTime":"0","endTime":"0","summary":"巨子生物北京时间04月28日，涨2.4%，卖空量成交70.48万股，较上一交易日增加139.08%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428211346a6cbba96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428211346a6cbba96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","LU2488822045.USD","SG9999004311.SGD","02367"],"gpt_icon":0},{"id":"2530452784","title":"鉅子生物：盤中漲近 3% 儲備 9 種膠原","url":"https://stock-news.laohu8.com/highlight/detail?id=2530452784","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530452784?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 11:36","pubTimestamp":1745811405,"startTime":"0","endTime":"0","summary":"据国家知识产权局中的专利信息，当前市场中大部分的重点公司已开发多种型别的重组胶原蛋白，不完全统计锦波生物和巨子生物均已储备 9 种型别的重组胶原蛋白类型。2025 年 1 月，巨子生物独家专利重组人Ⅳ型胶原蛋白获得国家知识产权局正式授权，并在 2 月上新以重组 IV 型胶原蛋白为核心成分的帧域密修系列产品；2024 年 8 月，公司重组人 XVII 型胶原蛋白，其制备方法及应用获得国家知识产权局正式授权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042814371997481125&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042814371997481125&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","SG9999004311.SGD","LU2488822045.USD","BK1207"],"gpt_icon":0},{"id":"2530497774","title":"鉅子生物盤中漲近3% 機構指中國重組膠原蛋白全球化提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2530497774","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530497774?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 10:57","pubTimestamp":1745809020,"startTime":"0","endTime":"0","summary":"　　该行续指，据国家知识产权局中的专利信息，当前市场中大部分的重点公司已开发多种型别的重组胶原蛋白，不完全统计锦波生物和巨子生物均已储备9种型别的重组胶原蛋白类型。2025年1月，巨子生物独家专利重组人Ⅳ型胶原蛋白获得国家知识产权局正式授权，并在2月上新以重组IV型胶原蛋白为核心成分的帧域密修系列产品；2024年8月，公司重组人XVII型胶原蛋白，其制备方法及应用获得国家知识产权局正式授权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-28/doc-ineustaw9123505.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02367","SG9999004311.SGD","LU2488822045.USD","BK1207"],"gpt_icon":0},{"id":"2530738411","title":"港股異動 | 鉅子生物(02367)漲近3% 機構指中國重組膠原蛋白全球化提速 建議關注行業龍頭佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=2530738411","media":"智通财经网","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530738411?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 10:18","pubTimestamp":1745806680,"startTime":"0","endTime":"0","summary":"2025年1月，巨子生物独家专利重组人Ⅳ型胶原蛋白获得国家知识产权局正式授权，并在2月上新以重组IV型胶原蛋白为核心成分的帧域密修系列产品；2024年8月，公司重组人XVII型胶原蛋白，其制备方法及应用获得国家知识产权局正式授权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-28/doc-ineustca2164108.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SG9999004311.SGD","BK1207","02367","LU2488822045.USD"],"gpt_icon":0},{"id":"2530549899","title":"中信證券：中國重組膠原蛋白全球化提速 “原料、妝、械”全面出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2530549899","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530549899?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 08:33","pubTimestamp":1745800419,"startTime":"0","endTime":"0","summary":"最后，中国重组胶原蛋白全球化提速，“原料、妆、械”全面出海。据国家知识产权局中的专利信息，当前市场中大部分的重点公司已开发多种型别的重组胶原蛋白，不完全统计锦波生物和巨子生物均已储备9种型别的重组胶原蛋白类型。领先、创新、高品质，中国重组胶原出海前景广阔。原料方面，中国重组胶原蛋白原料可靠性与有效性持续获得国内外认可。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286059.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1997245094.SGD","LU2495084118.USD","BK0012","LU1328615791.USD","BK1564","LU1655091616.SGD","02367","600030","LU1720050803.USD","SG9999004311.SGD","06030","BK0276","BK0196","LU2488822045.USD","LU2289578879.USD","LU1064130708.USD","LU1997245177.USD","BK0183","BK1521","LU1997244956.HKD","BK1207","LU2148510915.USD","BK1516","LU0405327148.USD","BK1147","LU1064131003.USD","BK0188","BK0028","LU0405327494.USD","LU1794554557.SGD"],"gpt_icon":0},{"id":"2530903980","title":"財報對對碰丨風口上的重組膠原蛋白生意：錦波生物毛利率連漲4年，鉅子生物連年下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2530903980","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530903980?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 16:23","pubTimestamp":1745569412,"startTime":"0","endTime":"0","summary":"近日，分别被称为港股与北交所“重组胶原蛋白第一股”的巨子生物、锦波生物相继交出2024年度成绩单：锦波生物净利翻倍，巨子生物的经调整净利是前者归母净利润的将近3倍。2024年，锦波生物的毛利率达到92.02%，并且连续4年上涨。与锦波生物相反，巨子生物的毛利率出现连年下滑的趋势。年报显示，巨子生物的毛利率从2021年的87.2%下滑至2022年的84.4%，再下滑至2023年的83.6%。2024年，因为销售成本增加及产品类型扩充，巨子生物毛利率再次下滑至82.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042517051394e23ba0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042517051394e23ba0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367"],"gpt_icon":0},{"id":"2529692732","title":"鉅子生物(02367)股東將股票由高盛(亞洲)證券轉入花旗銀行 轉倉市值26.07億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529692732","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529692732?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 08:22","pubTimestamp":1745454120,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，4月23日，巨子生物(02367)股东将股票由高盛(亚洲)证券转入花旗银行，转仓市值26.07亿港元，占比3.28%。巨子生物4月17日早上公布，配售最多3,500万股股份，相当于扩大后股本3.27%;配售价66.65港元，较上交易日(16日)收市价折让9.5%。集资总额23.33亿港元，所得净额22.94亿港元，配售及认购所得款项净额拟用于核心业务的发展及生态圈布局，包括品牌推广、市场营销、品类扩展、海外业务及研发投入;以及补充流动资金及作一般企业用途。巨子生物表示，集资主要用于海外业务发展，因其现金大部分在中国境内。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-24/doc-ineufnmc3683602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE0034235188.USD","BK4516","IE00BFXG1179.USD","LU2237443895.HKD","LU2237443622.USD","LU2360032135.SGD","IE0004091025.USD","LU1868836591.USD","BK4585","BK4534","LU0128525689.USD","LU2462157665.USD","LU0742534661.SGD","LU2471134523.USD","LU1868837300.USD","LU2237443382.USD","LU0310800965.SGD","LU2750360997.AUD","IE0004086264.USD","LU1868836757.USD","LU2750360641.GBP","BK1207","BK4504","LU2417539215.USD","BK4550","LU1668664300.SGD","LU2471134952.CNY","LU2237443978.SGD","BK4566","LU0061475181.USD","LU0251131958.USD","LU2237438978.USD","IE00BSNM7G36.USD","LU2488822045.USD","161027","LU1162221912.USD","LU2471134879.HKD","LU2125154935.USD","IE00B19Z3B42.SGD","LU2456880835.USD","LU0162691827.USD","02367","IE0002270589.USD","LU0980610538.SGD","SG9999004311.SGD","LU0106831901.USD","BK4207","BK4588","LU0130517989.USD"],"gpt_icon":0},{"id":"2529343744","title":"年入55億、毛利超八成，“饅化臉”風波刺破鉅子生物神話","url":"https://stock-news.laohu8.com/highlight/detail?id=2529343744","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529343744?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 15:24","pubTimestamp":1745306668,"startTime":"0","endTime":"0","summary":"2025年4月11日，关于“可复美面膜检出表皮生长因子成分”的话题冲上微博热搜，阅读量迅速突破4000万。据报道，陕西西安一位消费者秦女士 在使用“可复美重组胶原蛋白修复敷料（G型）”后，出现了面部发硬、肿胀的“馒化脸”症状。巨子生物的2024年是高歌猛进的一年，2024年度业绩公告显示，营收突破55亿元，同比增长57.2%，毛利首次超过45亿元，归母净利润更是达到20.62亿元，同比增长42.1%。首先，巨子生物的收入结构敲响了风险警钟。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/255705","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["SG9999004311.SGD","02367","BK1207","LU2488822045.USD"],"gpt_icon":0},{"id":"2529343799","title":"“風暴眼”中的鉅子生物：市場優勢漸失，至今未拿到Ⅲ類醫療器械批文","url":"https://stock-news.laohu8.com/highlight/detail?id=2529343799","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529343799?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 15:23","pubTimestamp":1745306606,"startTime":"0","endTime":"0","summary":"巨子生物旗下知名品牌可复美陷入一场成分“罗生门”。而这一被国家药监局明令禁止的成分，与巨子生物“未检出违禁成分”的官方回应形成尖锐对立。4月15日晚间，中国香料香精化妆品工业协会发布公告称，对可复美相关产品检测结果未见异常。2024年7月，“可复美”母公司巨子生物以“侵犯名誉权”为由将秦女士诉至法院，目前案件仍在审理中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/255681","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU2488822045.USD","BK1574","SG9999004311.SGD","02367","BK1100","BK1207","BK1222","BK1583","09997","09996"],"gpt_icon":0},{"id":"2529316728","title":"鉅子生物盤中漲超5% 陝西省藥監局通報多批次可復美產品均未檢出EGF","url":"https://stock-news.laohu8.com/highlight/detail?id=2529316728","media":"新浪网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529316728?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 11:48","pubTimestamp":1745293698,"startTime":"0","endTime":"0","summary":"巨子生物盘中涨超5%，截至发稿，股价上涨4.16%，现报75.10港元，成交额4.38亿港元。国货美妆头部品牌可复美近日深陷“EGF添加门”舆论漩涡。陕西省药监局针对近日媒体对可复美品牌“检出违禁添加表皮生长因子EGF”的报道做出通报，多批次可复美产品均未检出EGF。据悉，可复美为巨子生物的核心品牌，2024年销售收入达45.42亿元，同比增长62.9%，占公司总营收的82%。尽管如此，巨子生物的盈利前景依然稳健。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042212232894dd9fea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042212232894dd9fea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999004311.SGD","BK1207","02367","LU2488822045.USD"],"gpt_icon":0},{"id":"2529039394","title":"港股異動 | 鉅子生物(02367)早盤漲超5% 陝西省藥監局通報多批次可復美產品均未檢出EGF","url":"https://stock-news.laohu8.com/highlight/detail?id=2529039394","media":"智通财经网","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529039394?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 11:29","pubTimestamp":1745292540,"startTime":"0","endTime":"0","summary":"巨子生物早盘涨超5%，截至发稿，涨4.44%，报75.3港元，成交额4.22亿港元。消息面上，国货美妆头部品牌可复美近日深陷“EGF添加门”舆论漩涡。陕西省药监局针对近日媒体对可复美品牌“检出违禁添加表皮生长因子EGF”的报道做出通报，多批次可复美产品均未检出EGF。据悉，可复美为巨子生物的核心品牌，2024年销售收入达45.42亿元，同比增长62.9%，占公司总营收的82%。尽管如此，巨子生物的盈利前景依然稳健。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-22/doc-inetzeny4301594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2488822045.USD","SG9999004311.SGD","02367","BK1207","EGF"],"gpt_icon":0},{"id":"2529999493","title":"鉅子生物盤中異動 早盤股價大漲5.06%報75.750港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529999493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529999493?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 11:06","pubTimestamp":1745291164,"startTime":"0","endTime":"0","summary":"2025年04月22日早盘11时06分，巨子生物股票出现异动，股价急速拉升5.06%。截至发稿，该股报75.750港元/股，成交量462万股，换手率0.45%，振幅4.51%。资金方面，该股资金流入1.70393亿港元，流出1.09441亿港元。巨子生物股票所在的生物技术行业中，整体涨幅为3.64%。上市不到3年，巨子生物已公告两次配售，融资总金额近40亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422110605a461dd8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422110605a461dd8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","SG9999004311.SGD","02367","LU2488822045.USD"],"gpt_icon":0},{"id":"2529557843","title":"不差錢的鉅子生物連續高位融資，主力產品遭投訴","url":"https://stock-news.laohu8.com/highlight/detail?id=2529557843","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529557843?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 12:08","pubTimestamp":1745208515,"startTime":"0","endTime":"0","summary":"近日，巨子生物（02367）推出再融资计划后，股价应声下跌。4月17日早间，巨子生物发布公告称，公司与补足卖方及联席账簿管理人订立配售及认购协议，拟以每股66.65港元的价格配售3500万股现有股份，并通过补足认购同等数量新股份，预计募集资金总额约23.33亿港元，净额约22.94亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504213382733773.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1207","LU2488822045.USD","SG9999004311.SGD","02367"],"gpt_icon":0},{"id":"2528075772","title":"鉅子生物旗下可復美檢出違禁成分？陝西省藥監局通報","url":"https://stock-news.laohu8.com/highlight/detail?id=2528075772","media":"南方都市报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528075772?lang=zh_tw&edition=fundamental","pubTime":"2025-04-19 16:20","pubTimestamp":1745050800,"startTime":"0","endTime":"0","summary":"近日，巨子生物旗下护肤品牌可复美被消费者投诉含有违禁成分EGF一事引起热议。4月12日，可复美官方发布声明称，公司已委托两家专业检测机构分别采用两种检测方法对同批次产品独立检测，均未检出EGF。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250419162627973d6ae4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250419162627973d6ae4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02367","BK1207","SG9999004311.SGD"],"gpt_icon":0},{"id":"2528707106","title":"主品牌深陷EGF添加門 鉅子生物業績或將面臨劇烈波動- DoNews","url":"https://stock-news.laohu8.com/highlight/detail?id=2528707106","media":"iDoNews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528707106?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 10:02","pubTimestamp":1744941734,"startTime":"0","endTime":"0","summary":"然而，高增长表象下仍有隐忧，重营销轻研发、主品牌依赖与同质化竞争使得巨子生物高增长存疑。单一品牌依赖风险加剧，一旦可复美因市场竞争或质量问题受挫，公司整体业绩将面临剧烈波动。业内认为，若无法降低品牌依赖、提升研发投入突破技术瓶颈，巨子生物高增长神话或将面临终结。这场“EGF添加门”事件，不仅是对巨子生物产品质量的拷问，更是对其商业模式可持续性的深刻反思。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418100513973bfb06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418100513973bfb06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367","SG9999004311.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2528871147","title":"每日賣空追蹤 | 鉅子生物 04月17日賣空量成交184.6萬股，賣空比例為3.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528871147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528871147?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 20:29","pubTimestamp":1744892987,"startTime":"0","endTime":"0","summary":"巨子生物北京时间04月17日，跌2.1%，卖空量成交184.6万股，较上一交易日增加272.18%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417202951a6bdf8a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417202951a6bdf8a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999004311.SGD","BK1207","LU2488822045.USD","02367"],"gpt_icon":0},{"id":"2528796428","title":"北水動向|北水成交淨買入23.09億 北水繼續加倉科網股 全天拋售小米(01810)超13億","url":"https://stock-news.laohu8.com/highlight/detail?id=2528796428","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528796428?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 17:50","pubTimestamp":1744883448,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月17日港股市场，北水成交净买入23.09亿港元，其中港股通(沪)成交净买入5.08亿港元，港股通(深)成交净买入18.01亿港元。北水净卖出最多的个股是盈富基金、小米集团-W、中海油。北水重新加仓芯片股。小米集团-W遭净卖出13.42亿港元。4月14日，小米集团核心子公司小米通讯200亿元公司债项目状态更新为“提交注册”。此外有媒体报道称，小米原定于4月底举行的2025年投资者日因故延期至6月3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1280176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0211977185.USD","LU0642271901.SGD","LU2097828805.USD","SG9999002950.SGD","LU0823413660.USD","IE00B543WZ88.USD","LU2097828474.EUR","LU1868837565.USD","LU1880383440.USD","LU2488822045.USD","BK1207","XIACY","LU0048580855.USD","89988","LU1515016050.SGD","LU2226246903.HKD","HBBD.SI","LU0054450605.USD","BK1502","LU0348784397.USD","LU0307460666.USD","LU0348783233.USD","LU0516422952.EUR","LU0737861699.HKD","LU1981816686.USD","LU0572944931.SGD","LU0593848301.USD","LU2087589342.USD","LU0229945570.USD","HXXD.SI","LU0128522157.USD","LU1023057109.AUD","01810","LU0264606111.USD","LU1993786604.SGD","LU0084288322.USD","LU1188198961.HKD","02367","81810","LU0132412106.USD","LU0611395673.USD","LU0140636845.USD","LU0348805143.USD","LU2097828631.EUR","LU0228659784.USD","LU0499858438.USD","LU0797268264.HKD"],"gpt_icon":1},{"id":"1135025087","title":"北水動向 | 北水淨入23億港元，買鉅子生物、泡泡瑪特、赤峯黃金，沽盈富基金","url":"https://stock-news.laohu8.com/highlight/detail?id=1135025087","media":"老虎資訊","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135025087?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 17:49","pubTimestamp":1744883366,"startTime":"0","endTime":"0","summary":"北水今日淨入23.09億港元。其中：淨買入阿里巴巴-W 8.35億、騰訊控股7.82億、美團-W 7.37億、 $巨子生物(02367)$ 4.16億、泡泡瑪特2.27億、華虹半導體1.97億、 $赤峰黄金(06693)$ 1.82億；淨賣出盈富基金14億、小米集團-W 13.43億。據統計，北水連續10日淨買入美團，共計61.8467億港元；連續3日淨買入中國移動，共計9.0786億港元；連續3日淨賣出小米，共計28.1736億港元。","market":"hk","thumbnail":"https://static.tigerbbs.com/3e1ae3d0f75bebef8011736e9031acae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3e1ae3d0f75bebef8011736e9031acae"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSI","HSTECH","06693","09992","02800","02367","HSCEI"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02367\",params:#limit:5,,,undefined,":[{"date":"2025-06-17","symbol":"02367","amount":0.5921,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-18","defaultRemindTime":1750123800000,"name":"巨子生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-29","payableDate":"2025-06-18","currency":"CNY","dateTimestamp":1750089600000,"payDate":"2025-08-29"},{"date":"2025-03-26","symbol":"02367","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"盤後","dateTimestamp":1742918400000,"actualEps":null},{"date":"2024-08-19","symbol":"02367","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"盤後","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-06-17","symbol":"02367","amount":0.97,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2024-06-18","defaultRemindTime":1718587800000,"name":"巨子生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-05","payableDate":"2024-06-18","currency":"HKD","dateTimestamp":1718553600000,"payDate":"2024-07-05"},{"date":"2024-03-25","symbol":"02367","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02367\",market:\"HK\",,,undefined,":[{"executeDate":"2024-06-17","recordDate":"2024-06-18","paymentDate":"2024-07-05","value":0.97,"currency":"HKD"},{"executeDate":"2025-06-17","recordDate":"2025-06-18","paymentDate":"2025-08-29","value":0.5921,"currency":"CNY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02367\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4737,"buy":0.5263,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5263,"analysts":19,"updateTime":1745510400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02367\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02367","date":"2025-04-25","current":35.713683,"percent":0.859272,"low":18.546195,"twenty":25.864757,"median":29.297766,"eighty":33.896985,"high":60.214956,"avg":30.474592,"sd":6.56524,"marketCap":78403298400},"quantilePoints":[{"date":"2022-11-04","current":28.694216,"twenty":26.512834,"median":26.542085,"eighty":27.833364,"marketCap":25968654960},{"date":"2022-11-11","current":35.577583,"twenty":27.402937,"median":34.819032,"eighty":37.211633,"marketCap":32485133920},{"date":"2022-11-18","current":30.409033,"twenty":29.071802,"median":32.325114,"eighty":36.373143,"marketCap":27670720360},{"date":"2022-11-25","current":29.089974,"twenty":29.309257,"median":30.328688,"eighty":34.970742,"marketCap":26260437600},{"date":"2022-12-02","current":29.440115,"twenty":28.58665,"median":29.786096,"eighty":33.378719,"marketCap":27035200000},{"date":"2022-12-09","current":33.170723,"twenty":28.69893,"median":30.328688,"eighty":33.541593,"marketCap":30744000000},{"date":"2022-12-16","current":33.617702,"twenty":28.859591,"median":31.890871,"eighty":33.525219,"marketCap":31085600000},{"date":"2022-12-23","current":32.235512,"twenty":29.23003,"median":32.061881,"eighty":33.375102,"marketCap":29816800000},{"date":"2022-12-30","current":35.028223,"twenty":29.440115,"median":32.235512,"eighty":33.644993,"marketCap":32793600000},{"date":"2023-01-06","current":34.259259,"twenty":29.598569,"median":32.356077,"eighty":33.906187,"marketCap":32403200000},{"date":"2023-01-13","current":37.514633,"twenty":29.683286,"median":32.593587,"eighty":35.138095,"marketCap":36160800000},{"date":"2023-01-20","current":39.320225,"twenty":29.767789,"median":33.170723,"eighty":36.075015,"marketCap":37576000000},{"date":"2023-01-27","current":41.405428,"twenty":29.847916,"median":33.242723,"eighty":36.22764,"marketCap":39576800000},{"date":"2023-02-03","current":46.017337,"twenty":30.125824,"median":33.502098,"eighty":37.981351,"marketCap":44212800000},{"date":"2023-02-10","current":48.646066,"twenty":30.280481,"median":33.687805,"eighty":39.317619,"marketCap":46457600000},{"date":"2023-02-17","current":47.305048,"twenty":30.475064,"median":33.964048,"eighty":41.148897,"marketCap":44749600000},{"date":"2023-02-24","current":46.898265,"twenty":30.969524,"median":34.88282,"eighty":44.591745,"marketCap":43822400000},{"date":"2023-03-03","current":48.206405,"twenty":31.89643,"median":35.69024,"eighty":46.759698,"marketCap":45335200000},{"date":"2023-03-17","current":60.214956,"twenty":31.932315,"median":36.041848,"eighty":47.552658,"marketCap":56754400000},{"date":"2023-03-24","current":51.699724,"twenty":32.016899,"median":36.568073,"eighty":48.347792,"marketCap":49288000000},{"date":"2023-03-31","current":40.925047,"twenty":32.156582,"median":37.514633,"eighty":48.347792,"marketCap":46848000000},{"date":"2023-04-06","current":40.652856,"twenty":32.21578,"median":38.432644,"eighty":48.279626,"marketCap":46506400000},{"date":"2023-04-14","current":37.246115,"twenty":32.289273,"median":38.307612,"eighty":48.226605,"marketCap":42651200000},{"date":"2023-04-21","current":33.385259,"twenty":32.343692,"median":38.098031,"eighty":47.893759,"marketCap":38210400000},{"date":"2023-04-28","current":30.285025,"twenty":32.289273,"median":37.591448,"eighty":47.642868,"marketCap":34404000000},{"date":"2023-05-05","current":26.161165,"twenty":31.945964,"median":37.33158,"eighty":47.490756,"marketCap":29768000000},{"date":"2023-05-12","current":30.574645,"twenty":30.692284,"median":36.23263,"eighty":47.274687,"marketCap":34550400000},{"date":"2023-05-19","current":31.711515,"twenty":30.746535,"median":35.923479,"eighty":47.115193,"marketCap":35331200000},{"date":"2023-05-25","current":31.182824,"twenty":30.822604,"median":35.69024,"eighty":46.935066,"marketCap":34599200000},{"date":"2023-06-02","current":32.039153,"twenty":30.742861,"median":35.028223,"eighty":46.759698,"marketCap":35428800000},{"date":"2023-06-09","current":32.262222,"twenty":30.684805,"median":34.15987,"eighty":46.167812,"marketCap":35624000000},{"date":"2023-06-16","current":32.772734,"twenty":30.742861,"median":33.693297,"eighty":45.892894,"marketCap":36014400000},{"date":"2023-06-23","current":31.032471,"twenty":30.757557,"median":33.682729,"eighty":45.395124,"marketCap":33916000000},{"date":"2023-06-30","current":31.360803,"twenty":30.757557,"median":33.502098,"eighty":44.617559,"marketCap":33964800000},{"date":"2023-07-07","current":31.376956,"twenty":30.759705,"median":33.358016,"eighty":44.488487,"marketCap":33916000000},{"date":"2023-07-14","current":31.254408,"twenty":30.81937,"median":33.206723,"eighty":42.385946,"marketCap":34257600000},{"date":"2023-07-21","current":29.61115,"twenty":30.759705,"median":32.931722,"eighty":41.535665,"marketCap":32305600000},{"date":"2023-07-28","current":31.165322,"twenty":30.717545,"median":32.723027,"eighty":41.405428,"marketCap":33964800000},{"date":"2023-08-04","current":32.76763,"twenty":30.739187,"median":32.639512,"eighty":41.393979,"marketCap":35770400000},{"date":"2023-08-11","current":32.773868,"twenty":30.757557,"median":32.603384,"eighty":41.176747,"marketCap":35575200000},{"date":"2023-08-18","current":30.610294,"twenty":30.757557,"median":32.513854,"eighty":41.037499,"marketCap":32988800000},{"date":"2023-08-25","current":31.726668,"twenty":30.759705,"median":32.346784,"eighty":40.925047,"marketCap":34208800000},{"date":"2023-09-01","current":27.573424,"twenty":30.671209,"median":32.32831,"eighty":40.652856,"marketCap":36697600000},{"date":"2023-09-08","current":26.75169,"twenty":30.572064,"median":32.277824,"eighty":40.648282,"marketCap":35184800000},{"date":"2023-09-15","current":25.993592,"twenty":30.285025,"median":32.235512,"eighty":40.62978,"marketCap":34452800000},{"date":"2023-09-22","current":25.737943,"twenty":29.809068,"median":32.045764,"eighty":40.128892,"marketCap":33964800000},{"date":"2023-09-29","current":25.066298,"twenty":29.656075,"median":31.997803,"eighty":39.81665,"marketCap":33135200000},{"date":"2023-10-06","current":25.484582,"twenty":29.406098,"median":31.918666,"eighty":39.533705,"marketCap":33672000000},{"date":"2023-10-13","current":24.08012,"twenty":28.952772,"median":31.841433,"eighty":39.348774,"marketCap":31768800000},{"date":"2023-10-20","current":22.598372,"twenty":28.090884,"median":31.767659,"eighty":39.309801,"marketCap":29768000000},{"date":"2023-10-27","current":22.348635,"twenty":27.619397,"median":31.711663,"eighty":39.282609,"marketCap":29426400000},{"date":"2023-11-03","current":25.394448,"twenty":27.541831,"median":31.642548,"eighty":39.168886,"marketCap":33525600000},{"date":"2023-11-10","current":25.843419,"twenty":27.016595,"median":31.492944,"eighty":38.901953,"marketCap":34111200000},{"date":"2023-11-17","current":25.355932,"twenty":26.744612,"median":31.467436,"eighty":38.544946,"marketCap":33769600000},{"date":"2023-11-24","current":25.803053,"twenty":26.578324,"median":31.402883,"eighty":38.289787,"marketCap":34648000000},{"date":"2023-12-01","current":25.805078,"twenty":26.361375,"median":31.373452,"eighty":38.186355,"marketCap":34794400000},{"date":"2023-12-08","current":23.911147,"twenty":26.187226,"median":31.314709,"eighty":38.124793,"marketCap":32110400000},{"date":"2023-12-15","current":23.015122,"twenty":25.978956,"median":31.279712,"eighty":37.928033,"marketCap":31085600000},{"date":"2023-12-22","current":23.970526,"twenty":25.934891,"median":31.256547,"eighty":37.726838,"marketCap":32354400000},{"date":"2023-12-29","current":25.605578,"twenty":25.922833,"median":31.253927,"eighty":37.637537,"marketCap":34745600000},{"date":"2024-01-05","current":24.881987,"twenty":25.805078,"median":31.237017,"eighty":37.514633,"marketCap":33525600000},{"date":"2024-01-12","current":25.701327,"twenty":25.757517,"median":31.165322,"eighty":37.417045,"marketCap":34648000000},{"date":"2024-01-19","current":24.032983,"twenty":25.700075,"median":31.138965,"eighty":37.246115,"marketCap":32354400000},{"date":"2024-01-26","current":24.563567,"twenty":25.531167,"median":31.049171,"eighty":36.903516,"marketCap":32940000000},{"date":"2024-02-02","current":22.773078,"twenty":25.419215,"median":30.993085,"eighty":36.23263,"marketCap":30500000000},{"date":"2024-02-09","current":24.329361,"twenty":25.355932,"median":30.81937,"eighty":36.207681,"marketCap":32744800000},{"date":"2024-02-16","current":25.846624,"twenty":25.369207,"median":30.758631,"eighty":36.108181,"marketCap":34794400000},{"date":"2024-02-23","current":26.457355,"twenty":25.369207,"median":30.717545,"eighty":35.899805,"marketCap":35428800000},{"date":"2024-03-01","current":26.003824,"twenty":25.387892,"median":30.635655,"eighty":35.803782,"marketCap":34843200000},{"date":"2024-03-08","current":26.210688,"twenty":25.395134,"median":30.572064,"eighty":35.667709,"marketCap":35136000000},{"date":"2024-03-15","current":30.241869,"twenty":25.409765,"median":30.44783,"eighty":35.490153,"marketCap":40504000000},{"date":"2024-03-22","current":31.217759,"twenty":25.435494,"median":30.569793,"eighty":35.18968,"marketCap":41772800000},{"date":"2024-03-28","current":26.416103,"twenty":25.461641,"median":30.551779,"eighty":34.970062,"marketCap":41528800000},{"date":"2024-04-05","current":26.713065,"twenty":25.484582,"median":30.44783,"eighty":34.88282,"marketCap":41968000000},{"date":"2024-04-12","current":27.194611,"twenty":25.506915,"median":30.285025,"eighty":34.259259,"marketCap":42748800000},{"date":"2024-04-19","current":29.268508,"twenty":25.516475,"median":30.168532,"eighty":34.060481,"marketCap":45969600000},{"date":"2024-04-26","current":29.89571,"twenty":25.531167,"median":29.89571,"eighty":33.867614,"marketCap":46896800000},{"date":"2024-05-03","current":31.286129,"twenty":25.569811,"median":29.89571,"eighty":33.72816,"marketCap":49044000000},{"date":"2024-05-10","current":35.317002,"twenty":25.600357,"median":30.150227,"eighty":34.911901,"marketCap":51288800000},{"date":"2024-05-17","current":33.551674,"twenty":25.608792,"median":30.245106,"eighty":35.034138,"marketCap":48653600000},{"date":"2024-05-24","current":33.729665,"twenty":25.66112,"median":30.409033,"eighty":35.021714,"marketCap":48800000000},{"date":"2024-05-31","current":34.458991,"twenty":25.697876,"median":30.512617,"eighty":34.936642,"marketCap":49905929000},{"date":"2024-06-07","current":35.513458,"twenty":25.700826,"median":30.572064,"eighty":35.034138,"marketCap":51369298000},{"date":"2024-06-14","current":33.485895,"twenty":25.715973,"median":30.610294,"eighty":35.023883,"marketCap":48392099000},{"date":"2024-06-21","current":32.121521,"twenty":25.745773,"median":30.694377,"eighty":34.964455,"marketCap":46323198000},{"date":"2024-06-28","current":32.099848,"twenty":25.775731,"median":30.739187,"eighty":34.884174,"marketCap":46272737000},{"date":"2024-07-05","current":29.936022,"twenty":25.803458,"median":30.671209,"eighty":34.879736,"marketCap":43144155000},{"date":"2024-07-12","current":29.087996,"twenty":25.812746,"median":30.592469,"eighty":34.858532,"marketCap":41983552000},{"date":"2024-07-19","current":27.898783,"twenty":25.84406,"median":30.569793,"eighty":34.80307,"marketCap":40267878000},{"date":"2024-07-26","current":27.412372,"twenty":25.847354,"median":30.44783,"eighty":34.722361,"marketCap":39712807000},{"date":"2024-08-02","current":26.870727,"twenty":25.853895,"median":30.347362,"eighty":34.692602,"marketCap":38905431000},{"date":"2024-08-09","current":29.53175,"twenty":25.868681,"median":30.263126,"eighty":34.580226,"marketCap":43043233000},{"date":"2024-08-16","current":27.651468,"twenty":25.880225,"median":30.20526,"eighty":34.54918,"marketCap":40318339000},{"date":"2024-08-23","current":20.295155,"twenty":25.847354,"median":30.132576,"eighty":34.503268,"marketCap":39157736000},{"date":"2024-08-30","current":21.43279,"twenty":25.766624,"median":29.936022,"eighty":34.476088,"marketCap":41630325000},{"date":"2024-09-06","current":20.565575,"twenty":25.695677,"median":29.843348,"eighty":34.445054,"marketCap":39965112000},{"date":"2024-09-13","current":18.849184,"twenty":25.540828,"median":29.786096,"eighty":34.363297,"marketCap":36533764000},{"date":"2024-09-20","current":20.082561,"twenty":25.484582,"median":29.694562,"eighty":34.259259,"marketCap":39157736000},{"date":"2024-09-27","current":24.850231,"twenty":25.394448,"median":29.657792,"eighty":34.060481,"marketCap":48745326000},{"date":"2024-10-04","current":29.382648,"twenty":25.395362,"median":29.624666,"eighty":34.023673,"marketCap":57374157000},{"date":"2024-10-10","current":27.207172,"twenty":25.409765,"median":29.557165,"eighty":33.926357,"marketCap":52782206000},{"date":"2024-10-18","current":27.08831,"twenty":25.435494,"median":29.436062,"eighty":33.784845,"marketCap":52277596000},{"date":"2024-10-25","current":27.691447,"twenty":25.469288,"median":29.344363,"eighty":33.707844,"marketCap":53438199000},{"date":"2024-11-01","current":28.012496,"twenty":25.497982,"median":29.274876,"eighty":33.690002,"marketCap":54094192000},{"date":"2024-11-08","current":29.463901,"twenty":25.512651,"median":29.272452,"eighty":33.684759,"marketCap":56465859000},{"date":"2024-11-15","current":26.265769,"twenty":25.52529,"median":29.194481,"eighty":33.660087,"marketCap":49956390000},{"date":"2024-11-22","current":26.278217,"twenty":25.56015,"median":29.088985,"eighty":33.628618,"marketCap":49956390000},{"date":"2024-11-29","current":26.561468,"twenty":25.595136,"median":29.046664,"eighty":33.578085,"marketCap":50461000000},{"date":"2024-12-06","current":27.316407,"twenty":25.595136,"median":28.89327,"eighty":33.512207,"marketCap":51772986000},{"date":"2024-12-13","current":27.527865,"twenty":25.608792,"median":28.855293,"eighty":33.470601,"marketCap":52126213000},{"date":"2024-12-20","current":27.519045,"twenty":25.66112,"median":28.7635,"eighty":33.433798,"marketCap":51823447000},{"date":"2024-12-27","current":26.95045,"twenty":25.695677,"median":28.729978,"eighty":33.410147,"marketCap":50713305000},{"date":"2025-01-03","current":25.718533,"twenty":25.700075,"median":28.694216,"eighty":33.386493,"marketCap":48442560000},{"date":"2025-01-10","current":26.596222,"twenty":25.605578,"median":28.598093,"eighty":33.385259,"marketCap":49905929000},{"date":"2025-01-17","current":28.4557,"twenty":25.610934,"median":28.581538,"eighty":33.383573,"marketCap":53438199000},{"date":"2025-01-24","current":29.058848,"twenty":25.694577,"median":28.62658,"eighty":33.365541,"marketCap":54912816000},{"date":"2025-01-28","current":30.995109,"twenty":25.696776,"median":28.668851,"eighty":33.362531,"marketCap":58878741600},{"date":"2025-02-07","current":31.279146,"twenty":25.700576,"median":28.706002,"eighty":33.347316,"marketCap":59082122400},{"date":"2025-02-14","current":32.46032,"twenty":25.708209,"median":28.7635,"eighty":33.295849,"marketCap":61166775600},{"date":"2025-02-21","current":32.605291,"twenty":25.726297,"median":28.850334,"eighty":33.213923,"marketCap":61776918000},{"date":"2025-02-28","current":33.709306,"twenty":25.745773,"median":28.875802,"eighty":33.347316,"marketCap":63658190400},{"date":"2025-03-07","current":37.167941,"twenty":25.761386,"median":29.014465,"eighty":33.385999,"marketCap":70471447200},{"date":"2025-03-14","current":37.985438,"twenty":25.781535,"median":29.070262,"eighty":33.525362,"marketCap":72047648400},{"date":"2025-03-21","current":37.329923,"twenty":25.803863,"median":29.089974,"eighty":33.667635,"marketCap":70776518400},{"date":"2025-03-28","current":31.329348,"twenty":25.820414,"median":29.153791,"eighty":33.6911,"marketCap":69149472000},{"date":"2025-04-03","current":32.960917,"twenty":25.84406,"median":29.176551,"eighty":33.68679,"marketCap":72606945600},{"date":"2025-04-11","current":32.158951,"twenty":25.847354,"median":29.194481,"eighty":33.675182,"marketCap":70369756800},{"date":"2025-04-17","current":33.426462,"twenty":25.850275,"median":29.270028,"eighty":33.693297,"marketCap":73318778400},{"date":"2025-04-25","current":35.713683,"twenty":25.864757,"median":29.297766,"eighty":33.896985,"marketCap":78403298400}],"updateTime":1745836633310}}}